|
|
||||||||
J Thorac Cardiovasc Surg 2002;124:20-27
© 2002 The American Association for Thoracic Surgery
Cardiopulmonary Support and Physiology (CSP) |
Written on behalf of the Working Group on Extracorporeal Circulation and Mechanical Ventricular Assist Devices of the German Society for Thoracic and Cardiovascular Surgery.
Received for publication March 9, 2001. Revisions requested May 31, 2001; revisions received Sept 12, 2001. Accepted for publication Oct 1, 2001. Address for reprints: C. Bartels, MD, Clinic for Cardiac Surgery, Medical University of Luebeck, Ratzeburger Allee 160, 23538 Luebeck, Germany.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
|
Improving the quality of medical care by establishing medical practice guidelines has been vigorously promoted by the US health care system.
1 The responsible medical societies have developed practice guidelines on the basis of evidence-based medicine criteria for various procedures.
2-6 Thus a new paradigm of medical practice is emerging. Evidence-based medicine de-emphasizes intuition and unsystematic clinical experience as sufficient grounds for clinical decision making and stresses the examination of evidence from clinical and experimental research.
7
A survey concerning principles of CPB performance was sent to all German centers of cardiac surgery. The obtained results disclosed significant differences regarding CPB performance. As a consequence, the Working Group on Extra-Corporeal Circulation and Mechanical Ventricular Assist Devices of the German Society for Thoracic and Cardiovascular Surgery tried to develop a consensus document for the clinical application of CPB. Forty-eight major principles of CPB were formulated into questions to be addressed by a review of the scientific literature. The issues of interest covered nearly all relevant aspects of CPB (eg, optimum activated clotting time for routine CPB or during hypothermic circulatory arrest; anticoagulation management by the use of aprotinin; myocardial protection; technical safety aspects; pump flow rate, blood pressure, or both, for the different degrees of hypothermia; and washout of toxic metabolites from CPB material). In case of clinical studies, the key parameters for scientific evaluation of the investigated principles concentrated on patients' clinical outcomes and not on surrogate parameters.
Because it is impossible to deal adequately with each of the 48 questions within the scope of an article, the topics and our results are presented here in tabular form (Tables 1 and 2). As an example of our methodological approach, we selected a sample question (topics 38 and 39) that will be described in detail in the appropriate sections.
|
|
The clinical rationale behind this question was that neurologic injury and postoperative cognitive dysfunction appear to be the most frequent complications of CPB procedures. From 1970 to 1973, 8% of patients subjected to CPB died after a neurologic event; by contrast, from 1980 to 1983, 20% of postoperative deaths were related to severe neurologic injury.
8 More recently, a longitudinal assessment of neurocognitive function after coronary artery bypass grafting was reported.
9 These authors demonstrated an incidence of cognitive decline of 53% at discharge and of 42% after 5 years.
Although the cause of postoperative central nervous system dysfunction in patients subjected to CPB is multifactorial, microgaseous and solid emboli are particularly culpable and seem to be influenced by different brain perfusion rates of pH management.
| Scientific and pathophysiologic background |
|---|
|
|
|---|
Alpha-stat management will result in lower cerebral flow compared with pH-stat management. Intact cerebral autoregulation has been demonstrated in human subjects after alpha-stat strategy at temperatures from 21°C to 29°C.
10 In contrast, cerebral autoregulation was abolished, and it varied, depending on cerebral blood flow, when pH-stat was used.
11 In deep hypothermia the normal vascular responses are lost, and cerebral blood flow is dependent on the perfusion pressure with uncoupling of flow and metabolism. During moderate hypothermia, the variations in PCO2 between the different acid-base managements are only minor and do not seem to be clinically relevant.
12 In contrast, the difference in PCO2 during deep hypothermia approaches 80 mm Hg between the two acid-base strategies. The increased cerebral blood flow associated with pH-stat strategy may increase the risk of microemboli, cerebral edema, or high intracranial pressure. On the other hand, increased brain perfusion may result in improved cerebral cooling before circulatory arrest.
This article has two main aims: (1) to summarize the results obtained regarding the scientific quality of the reviewed publications and (2) to determine the scientific basis of currently applied CPB principles.
| Methods |
|---|
|
|
|---|
Step 1: Scientific level of the reviewed literature
All abstracts of articles identified by the search were reviewed by at least four members of the working group. Articles were selected for further review if one or more of the following criteria was met:
Step 2
The scientific quality of the manuscripts was assessed by at least four members of the working group regarding structure and content.
Manuscripts were selected for further review if they included the following:
Step 3
According to the methodological rigor, the selected articles were classified according to their scientific level:
] and low false-negative [ß] errors and high-quality meta-analysis) The level of scientific evidence assigned to each article was cross-checked by two other members of the working group. Any disagreements were resolved by means of consensus. For all articles, the adequate use of statistical methods was critically assessed and discussed with collaborating medical statisticians, for example:
Step 4: Classification of the scientific evidence on CPB principles
After all relevant articles had been graded with respect to their scientific level, the investigated principle (procedure or treatment) was classified according to a modification of the American Heart Association (AHA)/American College of Cardiology (ACC) guidelines for scientific evidence.
2,4,6
If a cardiac surgeon is to be convinced to critically assess his daily practice, more is generally required than advantages achieved by means of surrogate parameters. Therefore, we gave priority to studies analyzing different techniques or procedures with respect to patients' clinical outcomes (eg, mortality, morbidity, special organ function, transfusion requirements, length of stay at the intensive care unit, and overall hospital time; Table 1
).
Table 1
contains a brief version of the questions formulated concerning CPB principles, scientific level of reviewed articles, selected clinical end points, and their classification on the basis of the scientific evidence. In case no scientific articles were available for a specific question, "not available" was indicated. The single results of the scientific level of the evaluated manuscripts are available on our Web site (address given in the appendix).
Table 3 depicts the selection of key words, their combination, and the number of articles identified in connection with our sample question regarding acid-base management in adults.
|
| Results |
|---|
|
|
|---|
Many studies showed methodological problems (eg, imprecise study design or inappropriate statistical methods). As a result, most of the classified articles showed divergent results regarding individual principles of CPB performance. Thus, the scientific evidence regarding CPB principles could not be conclusive in these cases.
| Discussion |
|---|
|
|
|---|
Ideally, for each procedure or intervention, there should be direct and clear evidence from one or more studies that relate the application of this procedure (compared with specified alternatives) to the health outcomes of interest of a specific patient. However, rapid changes in medical practice, ethical considerations, and practical reasons make this desirable principle of patient care impossible to achieve. Thus, the limited scientific evaluation of current medical practice represents a general phenomenon and not one that is specific to the cardiothoracic surgical community.
Discussion of our sample question
The sample question was, "What is the appropriate acid-base management for optimal cerebral protection in adults with respect to moderate respiratory deep hypothermia?"
The study design and content of 124 articles identified were reviewed. For 42 original contributions, the scientific value was assessed. Six articles were selected for classification of the scientific evidence on the question as to which pH-management strategy should be used for moderate hypothermia in adults.
12-17 Although study design and statistical evaluation revealed some shortcomings, 5 of the contributions achieved scientific level II.
12-16 From this, the conclusion could be drawn that alpha-stat management is associated with a decreased incidence of postoperative cerebral dysfunction without negatively affecting other organs in adult patients subjected to moderate hypothermia and prolonged CPB time.
13-16 This conclusion contrasted with data reported by Bashein and colleagues (scientific level II).
12 However, they used bubble oxygenators without arterial filters in their study, which may imply significant influencing factors. On the basis of the articles selected for review, the scientific evidence of this CPB principle was classified as IIa. Postoperative cerebral dysfunction is obviously affected by underlying patient comorbidity. Thus, whether our conclusion can be applied to patients with preexisting cerebrovascular disease or uncontrolled hypertension remains unclear, and the scientific background is lacking. Therefore, we do not believe that our conclusion can be used as a general recommendation. This demonstrates that basic elements of CPB performance do not meet evidence-based medicine criteria.
As for the question of which pH-management strategy should be applied to adults undergoing deep hypothermic arrest, no valid scientific data currently exist. We selected this example to demonstrate that there is a pressing need to apply evidence-based medicine principles to CPB performance.
Thousands of publications cover the issue of CPB performance. However, the quality of most articles in other medical journals does not meet basic scientific criteria.
18 After examining the quality of medical knowledge, other authors reported that only 15% of medical interventions are supported by solid scientific evidence.
19
Although the quality of statistical analysis has improved and the application of more complex statistical procedures has increased during the past decades, imperfect study design and inadequate analysis remain an unresolved problem.
20 Articles now report larger numbers of analyzed cases than previously, yet the use of methods that aim to control type I error is rare.
21 True randomization requires exact evaluation of inclusion and exclusion criteria before a strata or blocked randomization protocol. In many publications the term "randomized" is used for clinical trial, although the investigation applied systematic allocation.
20 This condition limits the a priori scientific value of the study. For a scientific evaluation of CPB principles, more concise study designs and appropriate statistical evaluation seem to be mandatory.
Limitations of the study
Dickersin and colleagues
22 examined the sensitivity and precision of Medline searches for randomized trials. They concluded that although the indexing terms available for searching Medline have improved, the sensitivity "still remains unsatisfactory."
For this study, the appropriate use, selection, and combination of Medical Subject Headings were cross-checked by two other members of our working group. In addition, currently available monographs dealing with the issue of CPB were reviewed for missing publications. All original contributions and reviews retrieved in our search were also checked for missing articles. However, we cannot exclude the possibility that important contributions failed to come to our attention.
In contrast to the Task Force Committee of the AHA and ACC, our purpose in undertaking this investigation could not be the development of guidelines for CPB performance for the following reasons:
David Eddy, professor of health policy and management at Duke University, who began his medical life as a cardiothoracic surgeon, became a leader in the field of evidence-based medicine, and trained other physicians to achieve consensus for medical practice, stated the following in 1991: "Get doctors to understand how much they need reliable information. What could be worse than two millennia spent making life and death decisions with inadequate information?"
| Appendix |
|---|
|
|
|---|
Contributing investigators
J. Babin-Ebell, MD, Klinik und Poliklinik für Herz- und Thoraxchirurgie der Universität Würzburg, Würzburg
C. Bartels, MD, Klinik für Herzchirurgie, Uniklinikum Lübeck, Lübeck
M. Bechtel, MD, Klinik für Herzchirurgie, Uniklinikum Lübeck, Lübeck
C. Benk, Herz- und Kreislaufzentrum der Albert-Ludwigs-Universität, Kardiotechnik, Freiburg
U. Boeken, MD, Klinik und Poliklinik für Thorax- und Kardiovaskuläre Chirurgie, Heinrich-Heine-Universität, Düsseldorf
S. Christiansen, MD, Klinik für Thorax-, Herz- und Gefäßchirurgie, Westfälische Wilhelms-Universität, Münster
J. Cleuziou, Klinik für Herz- und Thoraxchirurgie, Klinikum Wuppertal GmbH, Wuppertal
T. Doenst, MD, Herz- und Kreislaufzentrum der Albert-Ludwigs-Universität, Freiburg
H. Doerge, MD, Klinik für Thorax-, Herz- und Gefäßchirurgie, Universitätsklinik Aachen, Aachen
A. Erasmi, MD, Klinik für Herzchirurgie, Uniklinikum Lübeck, Lübeck
P. Feindt, MD, Klinik und Poliklinik für Thorax- und Kardiovaskuläre Chirurgie, Heinrich-Heine-Universität, Düsseldorf
A. Gerdes, MD, Klinik für Herzchirurgie, Uniklinikum Lübeck, Lübeck
T. Hanke, Klinik für Herzchirurgie, Uniklinikum Lübeck, Lübeck
M. Heiermann, MD, Herzzentrum Wuppertal, Herz- und Thoraxchirurgie, Klinikum, Wuppertal GmbH, Wuppertal
S. Johannsson, MD, Herz- und Kreislaufzentrum der Albert-Ludwigs-Universität, Freiburg
E. Joubert-Hübner, Klinik für Herzchirurgie, Kardiotechnik, Uniklinikum Lübeck, Lübeck
M. Kemper, MD, Herz- und Kreislaufzentrum der Albert-Ludwigs-Universität, Freiburg
J. L. Kobba, MD, Herz- und Kreislaufzentrum der Albert-Ludwigs-Universität, Freiburg
M. Krause, Herz- und Kreislaufzentrum der Albert-Ludwigs-Universität, Kardiotechnik, Freiburg
A. Markewitz, MD, Abteilung für Kardiochirurgie, Bundeswehrkrankenhaus Koblenz, Koblenz
J. Martin, MD, Herz- und Kreislaufzentrum der Albert-Ludwigs-Universität, Freiburg
G. Matheis, MD, Klinikum der Wolfgang-Goethe-Universität, Klinik für Thorax,- Herz- und Gefäßchirurgie, Frankfurt
U. Mehlhorn, MD, Klinik und Poliklinik für Herz- und Thoraxchirurgie, Universität Köln, Köln
M. Misfeld, MD, Klinik für Herzchirurgie, Uniklinikum Lübeck, Lübeck
Dip. Biol. M. Misoph, Klinik und Poliklinik für Herz- und Thoraxchirurgie der Universität Würzburg, Würzburg
A. Nötzold, MD, Klinik für Herzchirurgie, Uniklinikum Lübeck, Lübeck
S. Pascucci, MD, Herzzentrum Bad Krozingen, Bad Krozingen
A. Philipp, MD, Klinik und Poliklinik für Herz-, Thorax- und herznahe Gefäßchirurgie, Klinikum der Universität Regensburg, Regensburg
W. Reents, MD, Klinik und Poliklinik für Herz- und Thoraxchirurgie der Universität Würzburg, Würzburg
J. Roetker, MD, Klinik für Thorax-, Herz- und Gefäßchirurgie, Westfälische Wilhelms-Universität, Münster
C. Schlensak, MD, Herz- und Kreislaufzentrum der Albert-Ludwigs-Universität, Freiburg
F.-X. Schmid, MD, Klinik und Poliklinik für Herz-, Thorax- und herznahe Gefäßchirurgie, Klinikum der Universität Regensburg, Regensburg
T. Tirilomis, MD, Klinik für Thorax-, Herz- und Gefäßchirurgie, Universitätsklinik Göttingen, Göttingen
D. Troitzsch, MD, Klinik für Herzchirurgie, Klinikum der Phillips-Universität, Marburg
A. Sam Sirath, Klinik für Herzchirurgie, Klinikum der Phillips-Universität, Marburg
H. Vetter, MD, Klinik für Herz- und Thoraxchirurgie, Klinikum Wuppertal GmbH, Wuppertal
C. Vicol, MD, Herzchirurgische Klinik Zentralklinikum, Augsburg
S. Vogt, MD, Klinik für Herzchirurgie, Klinikum der Phillips-Universität, Marburg.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
F. Loeffelbein, U. Zirell, C. Benk, C. Schlensak, and S. Dittrich High colloid oncotic pressure priming of cardiopulmonary bypass in neonates and infants: implications on haemofiltration, weight gain and renal function Eur. J. Cardiothorac. Surg., September 1, 2008; 34(3): 648 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Barner Operative Treatment of Coronary Atherosclerosis Ann. Thorac. Surg., April 1, 2008; 85(4): 1473 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Ferraris, F. H. Edwards, D. M. Shahian, and S. P. Ferraris Risk Stratification and Comorbidity Card. Surg. Adult, January 1, 2008; 3(2008): 199 - 246. [Full Text] |
||||
![]() |
K. G. Shann, D. S. Likosky, J. M. Murkin, R. A. Baker, Y. R. Baribeau, G. R. DeFoe, T. A. Dickinson, T. J. Gardner, H. P. Grocott, G. T. O'Connor, et al. An evidence-based review of the practice of cardiopulmonary bypass in adults: A focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J. Thorac. Cardiovasc. Surg., August 1, 2006; 132(2): 283 - 290.e3. [Full Text] [PDF] |
||||
![]() |
T. Jones and M. Elliott Paediatric CPB: Bypass in a High Risk Group Perfusion, July 1, 2006; 21(4): 229 - 233. [Abstract] [PDF] |
||||
![]() |
C. Schlensak Myocardial protection in congenital heart surgery MMCTS, November 29, 2005; 2005(1129): 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Belway, F D Rubens, D Wozny, B Henley, and H J Nathan Are we doing everything we can to conserve blood during bypass? A national survey Perfusion, September 1, 2005; 20(5): 237 - 241. [Abstract] [PDF] |
||||
![]() |
K. T. Lappegard, M. Fung, G. Bergseth, J. Riesenfeld, J. D. Lambris, V. Videm, and T. E. Mollnes Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation Ann. Thorac. Surg., March 1, 2004; 77(3): 932 - 941. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Doenst, C. Schlensak, and F. Beyersdorf Cardioplegia in pediatric cardiac surgery: do we believe in magic? Ann. Thorac. Surg., May 1, 2003; 75(5): 1668 - 1677. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Ferraris and S. P. Ferraris Risk Stratification and Comorbidity Card. Surg. Adult, January 1, 2003; 2(2003): 187 - 224. [Full Text] |
||||
![]() |
U. M Fischer, W. K Weissenberger, R D. Warters, H. J Geissler, S. J Allen, and U. Mehlhorn Impact of cardiopulmonary bypass management on postcardiac surgery renal function Perfusion, December 1, 2002; 17(6): 401 - 406. [Abstract] [PDF] |
||||
![]() |
V. A. Ferraris Heroes and evidence J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 11 - 13. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |